[1]Bove KE, Heubi JE, Balistreri WF, et al.Bile acid synthetic defects and liver disease:a comprehensive review[J].Pediatr Dev Pathol, 2004, 7 (4) ∶315-334.
|
[2]Monte MJ, Marin JJ, Antelo A, et al.Bile acids:chemistry, physiology, and pathophysiology[J].World J Gastroenterol, 2009, 15 (7) ∶804-816.
|
[3]Clayton PT, Leonard JV, Lawson AM, et al.Familial giant cell hepatitis associated with synthesis of3beta, 7alpha-dihydroxy and3beta, 7alpha, 12alpha-trihydroxy-5-cholenoic acids[J].J Clin Invest, 1987, 79 (4) ∶1031-1038.
|
[4]Cheng JB, Jacquemin E, Gerhardt M, et al.Molecular genetics of3beta-hydroxy-Delta5-C27-steroid oxidoreductase deficiency in16patients with loss of bile acid synthesis and liver disease[J].J Clin Endocrinol Metab, 2003, 88 (4) ∶1833-1841.
|
[5]Fischler B, Bodin K, Stjernman H, et al.Cholestatic liver disease in adults may be due to an inherited defect in bile acid biosynthesis[J].J Intern Med, 2007, 262 (2) ∶254-262.
|
[6]Jacquemin E, Setchell KD, O'Connell NC, et al.A new cause of progressive intrahepatic cholestasis:3beta-hydroxy-C27-steroid dehydrogenase/isomerase deficiency[J].J Pediatr, 1994, 125 (3) ∶379-384.
|
[7]Subramaniam P, Clayton PT, Portmann BC, et al.Variable clinical spectrum of the most common inborn error of bile acid metabolism3beta-hydroxy-Delta5-C27-steroid dehydrogenase deficiency[J].J Pediatr Gastroenterol Nutr, 2010, 50 (1) ∶910.
|
[8]Setchell KD, Suchy FJ, Welsh MB, et al.Delta4-3-oxosteroid5beta-reductase deficiency described in identical twins with neonatal hepatitis.A new inborn error in bile acid synthesis[J].J Clin Invest, 1988, 82 (6) ∶2148-2157.
|
[9]Lemonde HA, Custard EJ, Bouquet J, et al.Mutations in SRD5B1 (AKR1D1) , the gene encoding delta (4) -3-oxosteroid5beta reductase, in hepatitis and liver failure in infancy[J].Gut, 2003, 52 (10) ∶1494-1499.
|
[10]Gonzales E, Cresteil D, Baussan C, et al.SRD5B1 (AKR1D1) gene analysis in delta (4) -3-oxosteroid5beta-reductase deficiency:evidence for primary genetic defect[J].J Hepatol, 2004, 40 (4) ∶716-718.
|
[11]Ueki I, Kimura A, Chen HL, et al.SRD5B1gene analysis needed for the accurate diagnosis of primary3-oxo-Delta-steroid5beta-reductase deficiency[J].J Gastroenterol Hepatol, 2009, 24 (5) ∶776-785.
|
[12]Setchell KD, Schwarz M, O'Connell NC, et al.Identification of a new inborn error in bile acid synthesis:mutation of the oxysterol7alpha-hydroxylase gene causes severe neonatal liver disease[J].J Clin Invest, 1998, 102 (9) ∶1690-1703.
|
[13]Ueki I, Kimura A, Nishiyori A, et al.Neonatal cholestatic liver disease in an Asian patient with a homozygous mutation in the oxysterol7alpha-hydroxylase gene[J].J Pediatr Gastroenterol Nutr, 2008, 46 (4) ∶465-469.
|
[14]Ferdinandusse S, Denis S, Clayton PT, et al.Mutations in the gene encoding peroxisomal alpha-methylacyl-CoA racemase cause adult-onset sensory motor neuropathy[J].Nat Genet, 2000, 24 (2) ∶188-191.
|
[15]Setchell KD, Heubi JE, Bove KE, et al.Liver disease caused by failure to racemize trihydroxycholestanoic acid:gene mutation and effect of bile acid therapy[J].Gastroenterology, 2003, 124 (1) ∶217-232.
|
[16]Gallus GN, Dotti Mt, Federico A.Clinical and molecular diagnosis of cerebrotendinous xanthomatosis with a review of the mutations in the CYP27A1gene[J].Neurol Sci, 2006, 27 (2) ∶143-149.
|
[17]Keren Z, Falik-Zaccai TC.Cerebrotendinous xanthomatosis (CTX) :a treatable lipid storage disease[J].Pediatr Endocrinol Rev, 2009, 7 (1) ∶6-11.
|
[18]Bjorkhem I, Hansson M.Cerebrotendinous xanthomatosis:an inborn error in bile acid synthesis with defined mutations but still a challenge[J].Biochem Biophys Res Commun, 2010, 396 (1) ∶46-49.
|
[19]Clayton PT, Casteels M, Mieli-Vergani G, et al.Familial giant cell hepatitis with low bile acid concentrations and increased urinary excretion of specific bile alcohols:a new inborn error of bile acid synthesis[J].Pediatr Res, 1995, 37 (4) ∶424-431.
|
[20]Setchell KD, Heubi J, O'Connell NC, et al.Identification of a unique inborn error in bile acid conjugation involving a deficiency in amidation[J].In:Paumgartner G, Stiehl A, Gerok W.eds.Dordrecht/Boston/London:Kluwer Academic Publishers, 1997∶4347.
|
[21]Hofmann AF, Strandvik B.Defective bile acid amidation:predicted features of a new inborn error of metabolism[J].Lancet, 1988, 2 (8606) ∶311-313.
|
[22]Hubbard B, Doege H, Punreddy S, et al.Mice deleted for fatty acid transport protein5have defective bile acid conjugation and are protected from obesity[J].Gastroenterology, 2006, 130 (4) ∶1259-1269.
|
[23]Carlton VE, Harris BZ, Puffenberger EG, et al.Complex inheritance of familial hypercholanemia with associated mutations in TJP2and BAAT[J].Nat Genet, 2003, 34 (1) ∶91-96.
|
[24]Savolainen K, Kotti TJ, Schmitz W, et al.A mouse model for alpha-methylacyl-CoA racemase deficiency:adjustment of bile acid synthesis and intolerance to dietary methyl-branched lipids[J].Hum Mol Genet, 2004, 13 (9) ∶955-965.
|
[1] | Tao JIANG, Wenxian OUYANG, Yanfang TAN, Lian TANG, Hui ZHANG, Shuangjie LI. Clinical features and genetic analysis of congenital bile acid synthesis disorder type 2 in four children[J]. Journal of Clinical Hepatology, 2021, 37(8): 1898-1900. doi: 10.3969/j.issn.1001-5256.2021.08.029 |
[2] | Li AiQin, Dong Yi, Xu ZhiQiang, Wang FuChuan, Wang LiMin, Yan JianGuo, Cao LiLi, Wang Pu, Zhang Min. Progressive familial intrahepatic cholestasis type 3: A report of two cases in one pedigree[J]. Journal of Clinical Hepatology, 2020, 36(7): 1601-1604. doi: 10.3969/j.issn.1001-5256.2020.07.032 |
[3] | Zhao YouYou, Zhang Duan, Yin Xin, Wen XiaoYu, Gao PuJun. Glucocorticoid treatment of intrahepatic cholestasis caused by infectious cholangitis: A case report[J]. Journal of Clinical Hepatology, 2019, 35(2): 386-387. doi: 10.3969/j.issn.1001-5256.2019.02.031 |
[4] | Huang Qian, Zhang HaiBo, Li JingTao, Wei HaiLiang, Yan ShuGuang, Hui Yi, Chang ZhanJie. Research advances in the mechanism of action of intestinal microecology in intrahepatic cholestasis[J]. Journal of Clinical Hepatology, 2019, 35(10): 2355-2359. doi: 10.3969/j.issn.1001-5256.2019.10.050 |
[5] | Sui JingLi, Sun FengXia, Li XiaoLing, Zhang QiuXiang. Effect of Compound Yindan Decoction on the expression of farnesoid X receptor and multidrug resistance-associated protein 3 in rats with acute intrahepatic cholestasis[J]. Journal of Clinical Hepatology, 2018, 34(9): 1960-1966. doi: 10.3969/j.issn.1001-5256.2018.09.026 |
[6] | Xu Xin, Dai YiChen, Xuan ShiYing. Clinical features of cholestatic liver disease of 107 cases[J]. Journal of Clinical Hepatology, 2018, 34(11): 2364-2367. doi: 10.3969/j.issn.1001-5256.2018.11.019 |
[7] | Chai XiaoZhe, Zhu Wei, Luo XiangRong, Qian Feng, Zhu ChuanWu. A case report of benign recurrent intrahepatic cholestasis[J]. Journal of Clinical Hepatology, 2018, 34(1): 179-180. doi: 10.3969/j.issn.1001-5256.2018.01.038 |
[8] | Xu LingFen, Zhang WeiBo, Ma XueMei, Guo Jing, Wang Yang, Sun Mei. Value of tandem mass spectrometry in etiological diagnosis of cholestasis in infants[J]. Journal of Clinical Hepatology, 2015, 31(8): 1257-1261. doi: 10.3969/j.issn.1001-5256.2015.08.018 |
[9] | Obstetrics Subgroup, Chinese Society of Obstetrics and Gynecology, Chinese Medical Association. Guidelines for the management of intrahepatic cholestasis of pregnancy (2015)[J]. Journal of Clinical Hepatology, 2015, 31(10): 1575-1578. doi: 10.3969/j.issn.1001-5256.2015.10.003 |
[10] | Deng BaoCheng, Liu Pei. Current research on progressive familial intrahepatic cholestasis[J]. Journal of Clinical Hepatology, 2015, 31(10): 1599-1604. doi: 10.3969/j.issn.1001-5256.2015.10.009 |
[11] | Guo Jing, Xu LingFen, Sun Mei. Differential diagnosis of biliary atresia and intrahepatic cholestasis in children[J]. Journal of Clinical Hepatology, 2015, 31(8): 1252-1256. doi: 10.3969/j.issn.1001-5256.2015.08.017 |
[12] | Pang XiaoLi, Wang ChaoXia. Relationship of intestinal microecology with infantile cholestatic liver disease[J]. Journal of Clinical Hepatology, 2015, 31(8): 1221-1225. doi: 10.3969/j.issn.1001-5256.2015.08.010 |
[13] | Expert Committee on the 2015 update of expert consensus on the diagnosis and treatment of cholestatic liver disease. Expert consensus on the diagnosis and treatment of cholestatic liver disease: an update in 2015[J]. Journal of Clinical Hepatology, 2015, 31(10): 1563-1574. doi: 10.3969/j.issn.1001-5256.2015.10.002 |
[14] | Chen DongFeng, Sun WenJing. Intrahepatic cholestasis: from pathogenesis to diagnosis and treatment[J]. Journal of Clinical Hepatology, 2015, 31(10): 1559-1562. doi: 10.3969/j.issn.1001-5256.2015.10.001 |
[15] | Liu Yan, Huang ZhiHua. Clinical diagnosis and treatment of cholestatic hepatopathy in infants[J]. Journal of Clinical Hepatology, 2015, 31(8): 1218-1220. doi: 10.3969/j.issn.1001-5256.2015.08.009 |
[16] | Jiang Tao, Yao Yu, Ou YangWenXian, Tan YanFang, Li ShuangJie. Intrahepatic cholestasis caused by citrin deficiency: a clinical analysis of 43 infants[J]. Journal of Clinical Hepatology, 2014, 30(11): 1123-1126. doi: 10.3969/j.issn.1001-5256.2014.11.007 |
[17] | Guo HongMei, Zheng BiXia, Li Mei. Neonatal intrahepatic cholestasis caused by citrin deficiency due to SLC25A13 gene mutations: a clinical analysis of 21cases in Nanjing, China[J]. Journal of Clinical Hepatology, 2014, 30(11): 1127-1131. doi: 10.3969/j.issn.1001-5256.2014.11.008 |
[18] | Yang ZongGuo, Chen XiaoRong, Liu Cheng. The research advancement of pathogenesis of intrahepatic cholestasis jaundice related to chronic hepatits B[J]. Journal of Clinical Hepatology, 2011, 27(12): 1323-1326. |
[19] | Liu XingHui, Hou MinMin. Intrahepatic cholestasis of pregnancy[J]. Journal of Clinical Hepatology, 2011, 27(6): 598-600. |
[20] | Zhang AiMin, Wang HuiFen, Xu Biao, He WeiPing, Chen Jing, Hu JinHua. Clinical and pathological characteristics of patients with chronic drug-induced liver disease[J]. Journal of Clinical Hepatology, 2010, 26(3): 292-294. |